Lofibra 67mg Capsules

Manufacturer TEVA Active Ingredient Fenofibrate and Derivatives Capsules(fen oh FYE brate & dah RIV ah tives) Pronunciation fen-oh-FYE-brate
It is used to lower bad cholesterol, lower triglycerides, and raise good cholesterol (HDL).
🏷️
Drug Class
Antilipemic agent
🧬
Pharmacologic Class
Peroxisome proliferator-activated receptor alpha (PPARΞ±) agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jul 2004
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Lofibra is a medication used to help lower high levels of cholesterol and triglycerides (fats) in your blood. It works by helping your body break down and remove these fats more effectively, which can reduce your risk of heart disease and other related problems.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Some brands of this medication should be taken with food, while others can be taken with or without food. Check with your pharmacist to determine if your specific brand requires food. If you have difficulty swallowing, consult with your doctor.

Take your medication with a full glass of water. If you are also taking cholestyramine or colestipol, take these medications at least 4 hours before or 1 hour after your prescribed medication.

Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better. Swallow the medication whole; do not chew, crush, open, or dissolve it.

Storing and Disposing of Your Medication

Store your medication at room temperature with the lid tightly closed. Some brands require storage in the original container, so do not remove the anti-moisture cube or packet. If you are unsure about the storage requirements for your specific brand, consult with your doctor or pharmacist.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular dosing schedule. Do not take more than one dose in a 24-hour period, unless your doctor instructs you to do so.
πŸ’‘

Lifestyle & Tips

  • Continue to follow a low-fat, low-cholesterol diet as recommended by your doctor or dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Maintain a healthy weight.
  • Limit alcohol intake.
  • Quit smoking.
πŸ’Š

Available Forms & Alternatives

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 67 mg once daily with meals
Dose Range: 67 - 134 mg

Condition-Specific Dosing:

hypertriglyceridemia: Initial dose 67 mg once daily. May increase to 134 mg once daily if needed after lipid levels are re-evaluated.
primary hypercholesterolemia or mixed dyslipidemia: Initial dose 67 mg once daily. May increase to 134 mg once daily if needed after lipid levels are re-evaluated.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl 50-80 mL/min: No dose adjustment needed, but monitor renal function.
Moderate: CrCl 30-49 mL/min: Reduce dose to 50 mg once daily (using a different fenofibrate formulation if 50mg is not available for Lofibra, or consider alternative therapy). Avoid Lofibra 67mg. Monitor renal function closely.
Severe: CrCl < 30 mL/min: Contraindicated.
Dialysis: Contraindicated in patients with end-stage renal disease (ESRD) requiring dialysis.

Hepatic Impairment:

Mild: Use with caution. Monitor liver function tests.
Moderate: Use with caution. Monitor liver function tests.
Severe: Contraindicated in patients with active liver disease, including primary biliary cirrhosis and unexplained persistent liver function abnormalities.

Pharmacology

πŸ”¬

Mechanism of Action

Fenofibrate is a prodrug that is rapidly hydrolyzed to its active metabolite, fenofibric acid. Fenofibric acid activates peroxisome proliferator-activated receptor alpha (PPARΞ±), a nuclear receptor that regulates lipid metabolism. Through activation of PPARΞ±, fenofibric acid increases lipolysis and elimination of triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing production of apolipoprotein C-III (an inhibitor of lipoprotein lipase activity). It also increases the synthesis of apolipoproteins A-I and A-II, leading to an increase in HDL-C. These effects result in reductions in total cholesterol, LDL-C, VLDL-C, and triglycerides, and increases in HDL-C.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Variable, enhanced by food. Lofibra (nanocrystallized) formulation improves absorption and allows for more consistent absorption with or without food, though still often recommended with food for consistency.
Tmax: Approximately 4-5 hours for fenofibric acid.
FoodEffect: Absorption of fenofibric acid is increased by approximately 35% when Lofibra is taken with food compared to fasting conditions. However, Lofibra can be taken without regard to meals due to its nanocrystallized formulation.

Distribution:

Vd: Not readily available for fenofibric acid, but extensively distributed.
ProteinBinding: >99% (primarily to albumin) for fenofibric acid.
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 20-23 hours for fenofibric acid.
Clearance: Primarily renal clearance of fenofibric acid and its glucuronide conjugate.
ExcretionRoute: Urine (approximately 60% as fenofibric acid and its glucuronide conjugate), feces (approximately 25%).
Unchanged: Less than 2% of fenofibric acid is excreted unchanged in urine.
⏱️

Pharmacodynamics

OnsetOfAction: Lipid-lowering effects typically observed within 2-8 weeks.
PeakEffect: Maximal lipid-lowering effects usually seen within 6-8 weeks.
DurationOfAction: Effects persist as long as therapy is continued.

Safety & Warnings

⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be life-threatening.
Liver problems: Dark urine, fatigue, decreased appetite, stomach pain or upset, light-colored stools, vomiting, or yellow skin and eyes.
Pancreatitis: Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Gallstones: Sudden pain in the upper right belly area, right shoulder area, or between the shoulder blades, yellow skin and eyes, or fever with chills.
Severe joint pain or swelling: Contact your doctor if you experience intense joint pain or swelling.
Blood clots: Chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, color change, or pain in a leg or arm, or difficulty speaking or swallowing.
Muscle problems: Muscle pain or weakness, especially if accompanied by extreme fatigue, weakness, or fever. Notify your doctor if you experience difficulty urinating or a change in urine output, as this can lead to kidney problems.
Severe skin reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions, which can be life-threatening. Seek medical help immediately if you experience:
+ Red, swollen, blistered, or peeling skin
+ Red or irritated eyes
+ Sores in your mouth, throat, nose, eyes, genitals, or skin
+ Fever
+ Chills
+ Body aches
+ Shortness of breath
+ Swollen glands
Low blood cell counts: If your blood cell counts drop significantly, you may be at risk for bleeding problems, infections, or anemia. Contact your doctor if you experience:
+ Signs of infection, such as fever, chills, or sore throat
+ Unexplained bruising or bleeding
+ Extreme fatigue or weakness

Other Side Effects

Most people do not experience severe side effects, and some may only have mild or no side effects at all. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Headache
Back pain
Stomach pain

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or dark urine. This could be a sign of a serious muscle problem (rhabdomyolysis).
  • Yellowing of your skin or the whites of your eyes (jaundice), unusual tiredness, dark urine, light-colored stools, severe stomach pain, nausea, or vomiting. These could be signs of liver problems or gallbladder issues.
  • Signs of bleeding, such as unusual bruising, prolonged bleeding from cuts, or blood in your urine or stools (especially if also taking blood thinners like warfarin).
  • Severe abdominal pain that may spread to your back (pancreatitis).
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Gallbladder disease
+ Kidney disease
+ Liver disease
+ Elevated liver enzymes
If you are taking any of the following medications:
+ Atorvastatin
+ Fluvastatin
+ Lovastatin
+ Pitavastatin
+ Pravastatin
+ Rosuvastatin
+ Simvastatin
If you are breastfeeding or plan to breastfeed. Note that you should not breastfeed while taking this medication and may need to avoid breastfeeding for 5 days after your last dose. Consult your doctor to determine the best course of action.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help you verify that it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regularly undergo blood tests and other laboratory examinations as instructed by your doctor. Adhere to the dietary and exercise plan recommended by your doctor.

Be aware that this medication can cause liver problems, which may be severe and potentially life-threatening, requiring a liver transplant or resulting in death. If you have any concerns or questions, discuss them with your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to experiencing side effects.

If you are pregnant or planning to become pregnant, notify your doctor. It is crucial to discuss the potential benefits and risks of using this medication during pregnancy to make an informed decision.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • No specific symptoms of overdose have been reported. Symptoms would likely be an exaggeration of known side effects, such as muscle pain, liver enzyme elevations, or gastrointestinal upset.

What to Do:

In case of suspected overdose, contact a poison control center immediately (e.g., 1-800-222-1222 in the US) or seek emergency medical attention. Treatment is supportive and symptomatic. Hemodialysis is not effective in removing fenofibric acid.

Drug Interactions

🚫

Contraindicated Interactions

  • Active liver disease (including primary biliary cirrhosis and unexplained persistent liver function abnormalities)
  • Severe renal impairment (CrCl < 30 mL/min)
  • Pre-existing gallbladder disease
πŸ”΄

Major Interactions

  • Statins (HMG-CoA reductase inhibitors): Increased risk of myopathy, rhabdomyolysis, and acute renal failure. Use with caution, especially at higher statin doses. Consider lower doses of both agents and close monitoring.
  • Oral anticoagulants (e.g., Warfarin): Potentiates anticoagulant effect, leading to increased INR and risk of bleeding. Reduce anticoagulant dose by one-third and adjust based on INR monitoring.
  • Cyclosporine: Can cause reversible renal dysfunction. Monitor renal function closely.
🟑

Moderate Interactions

  • Bile acid sequestrants (e.g., Cholestyramine, Colestipol, Colesevelam): May reduce absorption of fenofibrate. Administer fenofibrate at least 1 hour before or 4-6 hours after bile acid sequestrants.
  • Ezetimibe: Increased risk of cholelithiasis and myopathy, though less pronounced than with statins. Monitor for adverse effects.
  • Colchicine: Increased risk of myopathy/rhabdomyolysis.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Fasting Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides)

Rationale: To establish baseline lipid levels and assess the need for therapy.

Timing: Prior to initiation of therapy.

Liver Function Tests (ALT, AST, ALP, Bilirubin)

Rationale: To establish baseline liver function and identify pre-existing liver disease, as fenofibrate can cause transaminase elevations.

Timing: Prior to initiation of therapy.

Renal Function (Serum Creatinine, eGFR/CrCl)

Rationale: To establish baseline renal function and guide dosing, as fenofibrate is primarily renally eliminated and contraindicated in severe renal impairment.

Timing: Prior to initiation of therapy.

Complete Blood Count (CBC)

Rationale: To establish baseline hematologic parameters, as transient decreases in hemoglobin, hematocrit, and WBC have been reported.

Timing: Prior to initiation of therapy.

πŸ“Š

Routine Monitoring

Fasting Lipid Panel

Frequency: Every 3 months for the first year, then periodically (e.g., annually) or as clinically indicated.

Target: Individualized based on treatment goals (e.g., LDL-C < 100 mg/dL, Triglycerides < 150 mg/dL).

Action Threshold: If lipid goals are not met, consider dose adjustment or alternative/adjunctive therapy. If triglycerides remain very high (>500 mg/dL), assess for secondary causes.

Liver Function Tests (ALT, AST)

Frequency: Every 3 months for the first year, then periodically (e.g., annually) or as clinically indicated.

Target: Within normal limits.

Action Threshold: Discontinue therapy if ALT or AST levels exceed 3 times the upper limit of normal (ULN) or if symptoms of liver injury develop. Consider discontinuation if persistent elevations > 2x ULN.

Renal Function (Serum Creatinine, eGFR/CrCl)

Frequency: Every 3 months for the first year, then periodically (e.g., annually) or as clinically indicated.

Target: Stable, within patient's baseline range.

Action Threshold: If significant increase in serum creatinine or decrease in eGFR/CrCl, consider dose reduction or discontinuation. Contraindicated if CrCl < 30 mL/min.

INR (if on Warfarin)

Frequency: Frequently (e.g., daily to weekly) upon initiation and dose changes of fenofibrate, then regularly as per standard warfarin monitoring.

Target: Individualized therapeutic range (e.g., 2.0-3.0).

Action Threshold: Adjust warfarin dose to maintain target INR. Be prepared for significant INR increases.

πŸ‘οΈ

Symptom Monitoring

  • Unexplained muscle pain, tenderness, or weakness (especially if accompanied by fever or malaise) - indicative of myopathy/rhabdomyolysis.
  • Dark urine - indicative of rhabdomyolysis.
  • Yellowing of skin or eyes (jaundice), dark urine, light-colored stools, severe stomach pain, nausea, vomiting, loss of appetite - indicative of liver injury or gallbladder issues.
  • Signs of bleeding (unusual bruising, prolonged bleeding from cuts, blood in urine or stools) - if on anticoagulants.

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies of fenofibrate in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects on fetal development at doses higher than human therapeutic doses.

Trimester-Specific Risks:

First Trimester: Potential for fetal harm based on animal data; avoid if possible.
Second Trimester: Potential for fetal harm based on animal data; avoid if possible.
Third Trimester: Potential for fetal harm based on animal data; avoid if possible.
🀱

Lactation

L3 (Moderate Concern). It is not known whether fenofibric acid is excreted in human milk. Fenofibrate is excreted in the milk of lactating rats. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Potential for unknown adverse effects; monitor infant for adverse reactions.
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Use is generally not recommended.

πŸ‘΄

Geriatric Use

Use with caution in elderly patients due to the higher incidence of decreased renal function in this population. Dose selection should be cautious, usually starting at the low end of the dosing range, and monitoring of renal function is important.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Lofibra is a nanocrystallized formulation of fenofibrate, which generally allows for more consistent absorption compared to older micronized formulations, even with or without food, though taking with food is often recommended for consistency.
  • Fenofibrate is primarily used for severe hypertriglyceridemia (often >500 mg/dL) to reduce the risk of pancreatitis, or as an adjunct to statins for mixed dyslipidemia when triglycerides and HDL-C remain problematic.
  • Regular monitoring of liver function tests (ALT, AST) and renal function (CrCl) is crucial due to potential for hepatotoxicity and renal impairment.
  • Patients should be advised to report any unexplained muscle pain, tenderness, or weakness immediately, especially if taking a statin concurrently, due to the risk of myopathy/rhabdomyolysis.
  • When co-administered with warfarin, fenofibrate can significantly increase INR; close monitoring and warfarin dose adjustment are necessary.
  • Fenofibrate can cause reversible increases in serum creatinine, which may not always indicate true renal impairment but warrants monitoring.
πŸ”„

Alternative Therapies

  • Other fibrates (e.g., Gemfibrozil)
  • Statins (e.g., Atorvastatin, Rosuvastatin, Simvastatin) - often first-line for LDL-C reduction, can also lower triglycerides.
  • Omega-3 Fatty Acid Ethyl Esters (e.g., Lovaza, Vascepa) - for severe hypertriglyceridemia.
  • PCSK9 inhibitors (e.g., Alirocumab, Evolocumab) - for severe hypercholesterolemia.
  • Niacin (Nicotinic Acid) - for dyslipidemia (less commonly used due to side effects).
  • Bile Acid Sequestrants (e.g., Cholestyramine, Colestipol, Colesevelam) - for LDL-C reduction.
πŸ’°

Cost & Coverage

Average Cost: Varies widely by pharmacy and insurance plan. Typically in the range of $100 - $300+ per 30 capsules
Generic Available: Yes
Insurance Coverage: Often Tier 2 or Tier 3 for brand-name, Tier 1 for generic fenofibrate.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to facilitate prompt and effective treatment.